COMPANY PROFILE / #2664
CureMetrix
San Diego, CAVenture Capital-Backed
OVERVIEW
Developer of medical image analysis technology designed to improve cancer survival rates worldwide. The company's technology uses a scientific algorithm to offer a precision tool for mammography that equips radiologists with the data-driven answers they need to support patients and their healthcare team, enabling radiologists to improve the accuracy of detection and classification of anomalies in mammography and patients to have improved clinical outcomes with reduced healthcare costs and increased assurance.
已融资69.00
最新估值83.50
员工数46
成立年份2014
公司概况
- Companies
- CureMetrix
- Description
- Developer of medical image analysis technology designed to improve cancer survival rates worldwide. The company's technology uses a scientific algorithm to offer a precision tool for mammography that equips radiologists with the data-driven answers they need to support patients and their healthcare team, enabling radiologists to improve the accuracy of detection and classification of anomalies in mammography and patients to have improved clinical outcomes with reduced healthcare costs and increased assurance.
- Website
- www.curemetrix.com
- HQ Location
- San Diego, CA
- Year Founded
- 2014
- Keywords
- anomaly detection system, breast cancer detection, cancer diagnostics, cancer screening, mammogram technology, mammography imaging, medical image analysis
- Competitors
- VoxelCloud, Arterys, Paige, Quantib, Aidoc, Thynk Health, Ibex Medical Analytics, Edda Technology, Agfa HealthCare, Vara, MRS Systems, Deep Lens, Tempus AI, Innovaccer, Lunit, Kheiron Medical Technologies, Zebra Medical Vision, SigTuple, Proscia, Ambra Health, HeartFlow, PenRad Technologies, Mevion Medical Systems, Niramai, Epic (Other Healthcare Technology Systems), Cyrcadia Health, Judi, Accuray, PredxBio, PathAI, Clarify, Keen Eye
- Ownership Status
- Privately Held (backing)
- Company Financing Status
- Venture Capital-Backed
融资与估值
- Total Raised
- 69.00
- First Financing Date
- 01-Aug-2014
- First Financing Size
- —
- First Financing Valuation
- —
- Last Financing Date
- 17-Sep-2024
- Last Financing Deal Type
- Later Stage VC
- Last Financing Size
- 30.00
- Last Financing Valuation
- —
- Last Financing Status
- Completed
- Last Known Valuation
- 83.50
- Last Known Valuation Date
- 20-Oct-2023
- Last Known Valuation Deal Type
- Later Stage VC
- Valuation Estimate
- 85.83
- Valuation Estimate Growth Rate
- 2.79%
- Active Investors
- Arben Ventures, CONNECT (San Diego), Institute for the Global Entrepreneur, Matt Seefeld, QB3, Tyler Kalklosch, UnitLeader, XB Ventures
- # Active Investors
- 8
- Acquirers
- —
团队与联系人
- Employees
- 46
- Employee Growth %
- 12.20%
- Employee History
- 2026: 46, 2025: 41, 2024: 40, 2023: 41, 2022: 41, 2021: 39, 2020: 35 E, 2019: 31 E, 2018: 27 E, 2017: 23 E, 2016: 19, 2015: 10, 2014: 7
- Primary Contact
- Kevin Harris
- Primary Contact Title
- Co-Founder, Chief Operating Officer, President & Board Member
- Primary Contact Email
- kevin@curemetrix.com
- Primary Contact Phone
- +1 (619) 339-9889
增长与经营
- Revenue
- —
- Revenue Growth %
- —
- Growth Rate
- 0.06%
- Growth Rate % Change
- —
- Growth Rate Percentile
- 89
- Size Multiple
- 9.22x
- Size Multiple % Change
- 0.00%
- Size Multiple Change
- 0.00x
- Size Multiple Percentile
- 92
- Majestic Referring Domains
- 330
- SimilarWeb Unique Visitors
- —
- SimilarWeb Unique Visitors Change
- —
- SimilarWeb Growth Rate
- —
- SimilarWeb Growth Rate Percentile
- —
- Success Probability Over Time – 1 Year
- 17%
- Success Probability Over Time – 3 Year
- 38%
- Success Probability Over Time – 5 Year
- 45%
记录来源：public.companies · 原始序号 #2664 · 所有字段均按数据库原值展示。